EP3220954A2 — Process for preparation of parenteral formulation of anidulafungin
Assigned to Gufic Biosciences Ltd · Expires 2017-09-27 · 9y expired
What this patent protects
The present invention discloses a freeze dried, micelle-forming surfactant free pharmaceutical formulation of anidulafungin along with a suitable solubilizing agent and acidifying agent for parenteral administration. The pharmaceutical formulation provides sufficient solubilizati…
USPTO Abstract
The present invention discloses a freeze dried, micelle-forming surfactant free pharmaceutical formulation of anidulafungin along with a suitable solubilizing agent and acidifying agent for parenteral administration. The pharmaceutical formulation provides sufficient solubilization and stabilization of anidulafungin thus improving the shelf life and reduces the likelihood of precipitation during storage. The invention further discloses a process of preparation thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.